Recently, a follow-up of the BRIDGES breast cancer case–control study was published, where the molecular subtypes of tumors associated with 9 breast cancer predisposition genes (ATM, BARD1, BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D and TP53) were reported [25]. This evidence concerns the gene TP53 and breast cancer.